Is NAD+ IV Therapy Safe? Cost, Evidence and What the Bronx Case Does and Doesn't Show

The short answer

NAD+ IV therapy is usually tolerable when a licensed clinician runs it slowly, but it is not proven to do anything for energy or aging, and it is not FDA-approved. Fast drips commonly cause nausea, cramping and chest pressure. The biggest risk is not NAD+ itself. It is an IV line placed by someone without a license, as the Bronx death showed.

Is NAD+ IV therapy safe?

For most healthy adults, the evidence points to uncomfortable rather than dangerous, with two large caveats: the data is very small, and the IV line carries risks of its own.

What the studies show:

• •Slow is tolerable. Eight healthy men received 750 mg of NAD+ over six hours. No adverse events were recorded, and liver tests did not worsen¹.
• •Faster is not. In a review of clinic records, all six clients given 500 mg by IV reported moderate to severe cramping, diarrhea, nausea, vomiting, a racing heart, throat pain, congestion and chest pressure during the drip. The symptoms stopped when the infusion ended, but the drip had to be slowed, to an average of 97 minutes². That review was run by staff of the clinic company that gave the infusions.
• •No long-term safety data. The 2026 PRISMA-guided systematic review found no eligible outcomes trial of IV NAD+ for anti-aging or wellness, so there is nothing measuring what months of regular drips do³.

Every IV, whatever is in the bag, also carries the risks of the line itself: infection, vein irritation, bruising, and in rare cases air entering the vein. Those risks depend on who places and watches the line, which is where the Bronx case comes in.

What happened in the Bronx, and what is still unknown?

On July 19, 2026, Elizabeth Baron, 27, lost consciousness almost immediately after an NAD+ IV infusion at the Bereshit Lifestyle Center in the Bronx. She was pronounced dead at the hospital that afternoon⁴.

The man who gave the infusion, Luis Rojas Cabrera, 55, told officers, according to court records, that he was a doctor in the Dominican Republic and held a physician assistant license in Puerto Rico, but was "not a licensed doctor in New York"⁵. He was arraigned hours after her death on charges of reckless endangerment and unauthorized practice of a profession⁴.

On September 21, 2026, Gothamist reported that New York City's Chief Medical Examiner had ruled the death a homicide. The cause was a cardiac air embolism, "caused by air introduced into Baron's IV catheter by an unlicensed practitioner"⁴. His lawyer told Gothamist that a homicide ruling "is not necessarily a murder, but may be caused by an accident." PIX11 reported that he had not been charged in connection with the homicide ruling and that the investigation was ongoing⁶.

What the case shows

• •An IV line is a medical procedure. Air in the line, not the NAD+ in the bag, is what the medical examiner found. The same death could have followed a saline or vitamin drip given the same way.
• •Licensing is the first check, not a formality. The person running the infusion was not licensed to practice medicine in New York.

What it does not show

• •It does not show that NAD+ is toxic. The ruling names air in the catheter as the cause, not the drug.
• •It does not show that licensed NAD+ clinics are dangerous. It is one case at one unlicensed operator.
• •It does not settle whether NAD+ drips are safe over time. That question is unanswered for a different reason: nobody has run the long-term study³.

Why does an NAD+ drip take hours?

Because NAD+ given quickly makes people feel ill. The symptoms in the clinic review, including nausea, cramping and chest pressure, came on during the drip and stopped when it ended, and the drip time stretched because staff slowed it down². In the six-hour study the rate was about 2 mg a minute and nobody reported a problem¹.

That is why a responsible clinic quotes hours, not minutes, for a full dose. One national chain describes its drip as "a slow drip process" that "commonly takes between 2-3 hours" for 300 mg, while one of its city menus lists an NAD+ service of about 30 minutes (Next Health review). A short session either uses a smaller dose or runs faster, so ask which before you book.

Another point from the infusion study: plasma NAD+ did not rise at all for the first two hours, and by the end it was about four times baseline¹. Where it goes, and whether any of it changes how you feel or age, has not been measured.

What does NAD+ IV therapy cost?

The clinic figures come from one national chain's own menus, covered in our Next Health review. Its national and city menus disagree, so check the menu for the location you would visit. A weekly drip at those prices costs more in a month than a year of most at-home plans.

The at-home figures are published prices from the telehealth providers we grade. Prices and terms for each are in NAD+ injections: benefits, side effects, dosage and cost and on the graded ranking.

Is IV better than an injection or a pill?

No route has an outcomes trial, so none is proven better.

The route-by-route evidence is in NAD+ injections vs IV vs oral. If you want NAD+ without a clinic visit, at-home injection providers include HealthRX, Oak and Direct Meds, each with a published monthly price; HealthRX's own product page states that NAD+ is "not FDA-approved for any use."

Is NAD+ IV therapy FDA-approved?

No. No NAD+ product is FDA-approved for any use. What clinics infuse is compounded by a pharmacy, and FDA says compounded drugs are not FDA-approved and are not reviewed for safety, effectiveness or quality before sale⁷.

On FDA's list of bulk ingredients nominated for 503A compounding, updated May 14, 2026, nicotinamide adenine dinucleotide (NAD) is in Category 1, under evaluation⁸. That means FDA has not decided whether NAD belongs on the list, and in the meantime does not intend to act against compounders using it, provided its conditions are met. It is not an approval.

How do you check a clinic before you book?

A few of these deserve detail:

• •Look the clinician up yourself. Every state runs a free online license lookup through its medical, nursing or professions board. A license in another country or state does not count where you are being treated.
• •Ask who places the IV and who watches it. You want a licensed nurse or clinician who stays nearby for the whole drip and can stop it.
• •Ask which pharmacy compounded the NAD+. A clinic should be able to name it and say whether it is a 503A or 503B pharmacy.
• •Ask about the rate. A clinic that says it will slow the drip if you feel nausea or chest pressure is describing correct practice. One that promises a full dose in 15 minutes is not.

Who should not book a drip without their own doctor's sign-off: anyone pregnant or under 18, and anyone with severe liver or kidney disease, an active infection, uncontrolled diabetes or significant heart disease. That is the caution list one NAD+ provider publishes for the drug.

Stop the drip and get help for chest pain that does not ease when the drip slows, sudden shortness of breath, confusion, or fainting.

The honest summary

NAD+ IV therapy has three small human studies behind it and no trial showing it slows aging or boosts energy. Run slowly by licensed staff, it is mostly a question of discomfort and cost. The one death in the news was ruled a homicide caused by air in the IV line, given by someone not licensed to practice, and that is the risk your checks can control.

Everything we have written on NAD+, from the molecule to the providers, starts at the NAD+ hub. The trial-by-trial evidence is in NAD+ for longevity.